image
Healthcare - Biotechnology - NASDAQ - US
$ 0.1538
-1.91 %
$ 6.11 M
Market Cap
-0.14
P/E
VIRX - COST OF REVENUE

Cost of Revenue VIRX - Viracta Therapeutics, Inc.

image
492 K
LAST VALUE
66.25%
2 YEAR CAGR
20.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR